Learn More
OBJECTIVES To examine the association between incident Alzheimer disease (AD), and plasma A beta 1-40 and A beta 1-42 levels in normal and mild cognitive impairment (MCI) subjects in a subgroup of participants of the Cardiovascular Health Study Cognition Study. METHODS We determined the plasma A beta 1-40 and A beta 1-42 levels of 274 nondemented subjects(More)
In specific-pathogen-free dogs experimentally infected with Borrelia burgdorferi by tick exposure, treatment with high doses of amoxicillin or doxycycline for 30 days diminished but failed to eliminate persistent infection. Although joint disease was prevented or cured in five of five amoxicillin- and five of six doxycycline-treated dogs, skin punch(More)
Metabolism of L-[U-14C]lysine was studied in the human autopsy tissues and the intact monkeys through intracerebroventricular and intravenous injections. The human tissues were more active in the metabolism of L-[14C]lysine to [14C]pipecolate than the rat tissues previously reported. This metabolism was equally active in the phosphate (pH 7) and the(More)
Blood-brain barrier transport of L-[1-14C]pipecolic acid was studied in the ray by single intracarotid injection using 3H2O as a diffusible internal standard. Brain uptake index (BUI) for L-[14C]pipecolic acid (0.036 mM) was found to be 18.1, 10.5, and 12.6 for the cerebral cortex, brain stem, and cerebellum, respectively which was substantially higher than(More)
The mechanism of the selective gliotoxicity of L-alpha-aminoadipate (L-alpha AA) is thought to involve its entry into glia as a substrate for glutamate transporters or, alternatively, its ability to inhibit glial glutamate transport. To clarify the properties of L-alpha AA as a transport substrate, we explored the ionic dependence, kinetics and pharmacology(More)
Intracerebral administration of L-alpha-aminoadipic acid (L-AAA) at 500 mg/kg body weight to rats caused a complex behavioral change with sporadic wet-dog shakes. Animals developed severe limbic seizures between 1 and 6 h after L-AAA injection, characterized by generalized convulsions. Twenty days after L-AAA injection kynurenine aminotransferase (KAT)(More)
  • K C Reichmann, P P Iannone, C Brinton, J Nakagawa, T Cusick, E M Kimber +12 others
  • 2011
We demonstrate an extended reach 60-km CWDM-TDMA PON with 40 Gb/s capacity for both down and upstream directions. The system leverages existing 10 Gb/s TDMA PON technologies and incorporates various subsystems such as volume manufacturable optical transmitters, a prototype 10-Gb/s burst-mode receiver, hybrid SOA-Raman amplifiers, and a cyclic CWDM(More)